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Abstract
Background: Frameless image‑guided radiosurgery (IGRS) is a safe and effective
noninvasive treatment for trigeminal neuralgia (TN). This study evaluates the use
of frameless IGRS to treat patients with refractory TN.
Methods: We reviewed the records of 20 patients diagnosed with TN who
underwent frameless IGRS treatments between March 2012 and December 2013.
Facial pain was graded using the Barrow Neurological Institute (BNI) scoring
system. The initial setup uncertainty from simulation to treatment and the patient
intrafraction uncertainty were measured. The median follow‑up was 32 months.
Results: All patients’ pain was BNI Grade IV or V before the frameless IGRS
treatment. The mean intrafraction shift was 0.43 mm (0.28–0.76 mm), and the
maximum intrafraction shift was 0.95 mm (0.53–1.99 mm). At last follow‑up,
8 (40%) patients no longer required medications (BNI 1 or 2), 11 (55%) patients
were pain free but required medication (BNI 3), and 1 (5%) patient had no pain
relief (BNI 5). Patients who did not have prior surgery had a higher odds ratio for
pain relief compared to patients who had prior surgery (14.9, P = 0.0408).
Conclusions: Frameless IGRS provides comparable dosimetric and clinical
outcomes to frame‑based SRS in a noninvasive fashion for patients with medically
refractory TN.
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INTRODUCTION
Trigeminal neuralgia (TN) causes brief and severe
intensity unilateral facial pain that is electric shock‑like,
shooting, stabbing, or sharp in quality.[15] It occurs in one
or more divisions of the trigeminal nerve, and there is no
clinically evident neurological deficit.[15] Most cases of
TN are produced by compression of the trigeminal nerve
root within a few millimeters of entry into the pons,
specifically the root entry zone.[20] Painful triggers include
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chewing, brushing the teeth, wind on the face, or touching
the face. It is more common in people >50 years and
often affects women more than men.[23] The incidence
of TN is approximately 5 new cases per 100,000 people
annually.[9] Several schemes have been developed for
the classification of trigeminal neuralgia, including the
Barrow Neurological Institute (BNI) scoring system and
the Burchiel classification scheme.[11,27]
The initial treatment of TN includes medical
management
with
anticonvulsants
and
other
medications, which are typically used for neuropathic
pain. Approximately 90% of patients with new‑onset TN
attain either complete or significant relief of symptoms
following medical therapy.[23] While TN has been treated
with invasive surgical techniques such as microvascular
decompression,[25,28,36] radiofrequency rhizotomy,[3] and
balloon compression,[2,17,31] stereotactic radiosurgery (SRS)
has proven successful with its zero mortality and low
morbidity.[29] However, radiosurgery has a lower likelihood
of complete pain relief and a higher likelihood of
pain recurrence compared with either microvascular
decompression or percutaneous rhizotomy.[8] In 1951,
Leksell reported the initial use of SRS for the treatment
of TN.[19] Utilizing an orthovoltage X‑ray machine and
stereotactic localization, this method offered long‑lasting
pain relief without complications in two patients.
Traditional SRS treatment of TN has used a rigid
invasive headframe to deliver between 80–90 Gy to a
point within millimeters of the brainstem. We conducted
a retrospective study of 20 patients who underwent
frameless image‑guided radiosurgery (IGRS) by treating
a point along the trigeminal nerve ranging from the
dorsal root entry (DRE) zone to the retro Gasserian
ganglion. This approach ensured submillimeter accuracy
and allowed more complicated SRS planning over several
days. We present our clinical findings and patient
positioning data pertaining to the use of frameless
IGRS using the BrainLAB Novalis ExacTrac system
(BrainLAB AG, Feldkirchen, Germany) in the treatment
of TN. The present study also compares the patient
responses following the treatment for TN with frameless
IGRS to frame‑based linear accelerator (LINAC) SRS
based on historical published data.

MATERIAL AND METHODS

Patient population

Between March 2012 and December 2013, a total of 20
individuals with TN underwent frameless IGRS at our
institution. The Institutional Review Board approved
the retrospective review of these cases. The primary
characteristics of these patients are presented in Table 1.
The median age was 73 years (range 52–85); there were
8 males and 12 females. All patients were treated with
medical therapy (e.g., carbamazepine, gabapentin, or
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Table 1: Improvement in pain scores from the baseline to
the last follow‑up of trigeminal neuralgia patients
Covariates

N (%)

Univariate Model
Adjusted Odds Ratio
(95% CI)

Gender
Male
Female
Ever Smoke
Yes
No
Hypertension
Yes
No
BMI
<25
25-30
>30
Diabetes
Yes
No
Hyperlipidemia
Yes
No
Previous procedure for TN
Yes
No
Laterality
Left
Right
Distribution/Division
1 (V1; V1, V2; V1, V2, V3)
2 (V2; V2, V3; V3)

P

8 (40)
12 (60)

Reference
1.20 [0.231, 6.218]

10 (50)
10 (50)

3.235 [0.60,17.48]
Reference

11 (55)
9 (45)

Reference
1.324 [0.261, 6.723]

0.7350

6 (30)
8 (40)
6 (30)

Reference
1.268 [0.18,8.90]
1.000 [0.125, 8.00]

0.8113
0.9999

5 (25)
15 (75)

Reference
2.133 [0.321, 14.16]

0.4327

10 (50)
10 (50)

1.268 [0.252, 6.372]
Reference

0.8290
0.1726

0.7735

4 (20)
Reference
16 (80) 14.886 [1.119, 197.953] 0.0408
12 (60)
Reference
8 (40) 12.894 [1.665, 99.837] 0.0144
5 (25)
15 (75)

Reference
1.158 [0.180, 7.446]

0.8773

BMI: Body mass index, TN: Trigeminal neuralgia

baclofen) prior to the frameless IGRS. Four patients
underwent a procedure for TN at another institution prior
to the frameless IGRS: (1) One underwent a rhizotomy
4 months before the SRS; (2) another had a microvascular
decompression followed by two rhizotomies within
28 months before the frameless IGRS; (3) one had 3
gamma knife procedures, a microvascular decompression,
and a rhizotomy within a 12‑year period before the
frameless IGRS; and (4) another underwent 2 balloon
rhizotomies before the frameless IGRS. Table 1 also
highlights the lateralization of the TN, the division of the
TN affected, and other comorbidities. One patient was
diagnosed with multiple sclerosis. The median body mass
index (BMI) of the patients was 27.1 (range 17.2–41.0).
All 20 patients
neurologist, and
frameless IGRS
frameless IGRS

were evaluated by a neurosurgeon,
radiation oncologist and underwent
treatment. One patient underwent
retreatment after failing the first
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treatment. Each patient was scored pre‑ and
post‑ frameless IGRS based on the Barrow Neurological
Institute (BNI) pain intensity scoring criteria (I: no pain;
II: occasional pain, not requiring medication; III: some
pain, controlled with medication; IV: some pain, not
controlled with medication; V: severe pain/no pain
relief).[6,27] All patients had a BNI of either IV or V prior
to the initial frameless IGRS procedure.

Treatment method
Simulation

After each patient signed the informed consent, a
bivalve‑style thermoplastic mask was fabricated to
immobilize the head. All patients were simulated and
treated supine and head‑first. Next, a stereotactic localizer
frame was attached to the imaging frame, and then patients
underwent a 0.6 mm axial slice computed tomography (CT)
scan using 40‑slice Siemens Sensation Open (Siemens,
Munich, Germany) from the vertex to the third cervical
vertebra. We obtained a 0.5 mm constructive interference in
a steady state (CISS) T2 magnetic resonance imaging (MRI)
sequence using a three Tesla magnet with zero gantry tilt
and registered the CT and MRI datasets using BrainLAB
iPlan RT Image software, versions 4.1.0 and 4.1.1 [Figure 1].

Treatment planning

The affected side trigeminal nerve and organs at risk were
contoured by the neurosurgeon and radiation oncologist
on the fused dataset. The isocenter was placed in the
retrogaussarian space. The SRS plan was prescribed at
the isocenter, and all plans used between seven and nine
non‑coplanar arcs with fixed diameter cones ranging from
4.0 to 7.5 mm aperture, with total scatter factors of 0.669
and 0.815, respectively. Each arc used between 60 and
140 degrees. The mean maximum brainstem dose was
31 Gy (range 8–57 Gy), the mean dose to 0.1 cc of the
brainstem was 9 Gy (range 4–15 Gy), and the mean dose
to 1 cc of the brainstem was 3 Gy (range 1–6 Gy).

a

b

c
Figure 1: (a and b) Thermoplastic mask used for patient
immobilization. (c) The CISS MR utilized for target definition.The
arrow depicts the dorsal root entry zone
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Treatment delivery

Patients were placed in the simulation position on the
LINAC treatment couch and the immobilization mask
was applied. An optical tracking array for localization was
used to determine the initial position. Stereoscopic X‑rays
were fused with the digitally reconstructed radiographs
from simulation, allowing Exactrac to measure the shift
from simulation to treatment. Corrections to patient
positioning were made for deviations exceeding 0.5 mm
and 1° using a robotic couch with six degrees of freedom.
The mean setup uncertainty from simulation to treatment
was 2.9 mm (±1.5 mm). Before each arc was delivered,
an additional set of stereoscopic X‑rays was obtained.
Total treatment time ranged from 35 to 100 minutes.
Three patients received 80 Gy, and 16 received 85 Gy.
One patient was scheduled to receive 85 Gy, however,
he experienced severe postnasal drip coupled with
claustrophobia and was treated with 22.65 Gy.

Quality assurance

There were both LINAC and patient specific quality
assurance measures taken to maximize the accuracy
of treatment. The cones were commissioned with
small‑field dosimetry techniques for treatment planning.
Immediately prior to treatment delivery, a Winston–Lutz
test was performed to verify that the treatment and
imaging isocenter were congruent. The resulting
root‑mean square geometric error was 0.58 ± 0.2 mm.

Follow‑up

Patients were assessed 1 month after the procedure and
then approximately every 2 to 3 months. Each patient
was evaluated by the treating neurosurgeon and/or
radiation oncologist. A physical examination with facial
sensation was performed, and a BNI score was assigned.

Data analysis

Primary data analyses were focused on assessing the
outcome of change in BNI score from study entry to
BNI measured at the last follow‑up. This score ranged
from −1 (change from 4 to a 5 in 1 patient) to a 4
(in 3 patients going from a 5 down to a 1). This score
change variable was used to create 3 categories of
pain improvement: score change of 3 or 4 = marked
improvement (n = 7 patients), score change of
2 = moderate improvement (n = 7 patients),
and score change of −1 or 1 = some/none/worse
improvement (n = 6). This 3‑level ordinal variable was
then used as the outcome to assess whether variations in
the outcome were due to clinical factors as determined
by a proportional odds model using Statistical Analysis
Software (SAS) V9.3. The proportional odds assumption
was assessed using the score test and was not rejected
for any of the covariates examined [Table 1] effectively
leading to one odds ratio estimate that succinctly
described marked or moderate improvement compared
to some/none/worse improvement. Model goodness of fit
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was assessed using the deviance Chi‑square statistic, and
was found to be adequate for each univariate model that
was fit.
Descriptive analyses for the outcome and relevant
covariates
are
reported
as
frequencies
and
percentage [Table 1]. Univariate model results are
reported as odds ratio (OR) and 95% confidence
limit (95% CI) as well as the P value [Table 1].

RESULTS
Between March 2012 and December 2013, a total of
20 patients (12 women and 8 men) diagnosed with
TN underwent frameless IGRS [Table 1]. The median
age was 73 years (range 52–85 years). Twelve (60%)
patients were treated for left‑sided pain, and 8 (40%)
had right‑sided pain. The most common distribution
of pain was V2 only (8 patients; 40%), followed by
V2‑V3 (6 patients; 30%), V1 only (3 patients; 15%),
and equal numbers of V3 only, V1‑V2, and V1‑V2‑V3
(1 patient each; 5%). The median follow‑up for the
20 patients was 32 months (range 21.6–41.2 months).

Intraprocedural positioning

Following initial alignment, repeat X‑rays were performed
during the treatment delivery to verify that the patient
position was maintained. The mean intrafraction shift was
0.43 mm (0.28–0.76 mm), and the maximum intrafraction
shift was 0.95 mm (0.53–1.99 mm) [Figure 2]. Rotational
errors greater than 1 degree required correction with
repositioning using the automated couch corrections and
confirmatory stereoscopic X‑rays.

Outcomes

With a median follow-up of 32 months, the response
to the frameless IGRS treatment was based on the
BNI score determined at follow‑up appointments

Figure 2: Monitoring of the intrafraction motion during frameless
IGRS. The mean intrafraction shift was 0.43 mm, and the mean
maximum intrafraction shift was 0.95 mm
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with the neurosurgeon and/or radiation oncologist.
Good‑to‑excellent results were defined as a BNI score of
I–III. Of the 20 patients who underwent frameless IGRS
evaluated at their last follow‑up, 1 (5%) patient had a
post SRS BNI score of V due to failure of the frameless
IGRS procedure. Eleven (55%) patients had a BNI of
III as they continued to consume their TN medications
following frameless SRS. One patient had occasional
pain without needing medication and, therefore, was a
BNI II. Seven (35%) patients scored a BNI of I as they
had attained complete improvement of their symptoms
and had discontinued all medications for TN. Thus,
19 (95%) of the 20 patients had a BNI of III or less at
last follow‑up.
The qualitative change in BNI score was marked in 7 (35%)
patients, moderate in 7 (35%), and some/none/worse in
6 (30%) patients. A univariate analysis was performed
to determine if any clinical factors were associated with
outcomes from SRS [Table 1]. Patients who did not
have a prior surgery had increased odds for marked or
moderate improvement compared to some/none/worse
improvement by 14.9 times (P = 0.0408) compared to
having had prior surgery. Having TN on the left side
was associated with a 12.9 times (P = 0.0144) greater
odds compared to the right side of either marked or
moderate improvement compared to some/none/worse
improvement in pain. Covariates having no effect on the
odds for improvement include gender, smoking status,
hypertension, BMI, diabetes status, hyperlipidemia status,
and distribution/division (all P > 0.05).

Complications

No complications were reported by the TN patients.
Physical examination performed by the neurosurgeon
following the frameless IGRS procedure detected no new
sensation or motor abnormalities.

Salvage treatments

Six patients required a salvage procedure after the
frameless IGRS. Two underwent an MVD after the
frameless IGRS. The first patient underwent the MVD
1 month after the frameless IGRS and attained complete
pain relief 7 months after the MVD. Nine months later,
he experienced a recurrence of his facial pain requiring
medications. He continued to consume medications at
the last follow‑up 12 months later. Of note, this patient
had undergone a rhizotomy prior to the frameless IGRS.
Another patient underwent an MVD 13 months after the
frameless IGRS and had complete pain relief 1 month
later. One patient underwent a second frameless IGRS
5 months after the first one, receiving 85 Gy at each
procedure. He experienced complete pain relief 2 months
later. Another patient had a rhizotomy 10 months after
the initial frameless IGRS and continued to require
antiepileptic medications at last follow‑up 22 months
later. One patient underwent a rhizotomy 39 months
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after the initial frameless IGRS. Interestingly, this patient
had undergone two rhizotomies and one MVD prior
to the frameless IGRS. The final patient experienced
increased pain following the frameless IGRS procedure
and was treated with an increased dosage of antiepileptic
medications.
The two additional patients who underwent a procedure
for TN prior to the frameless IGRS were both assigned
a BNI of III at the last follow‑up indicating that they
continued to consume TN medications.

DISCUSSION
Since the advent of SRS techniques in the treatment
of TN, the most common method utilized has been
the gamma knife procedure.[10,14,21,22] Studies have shown
that 77–95% of patients treated with gamma knife SRS
have attained a benefit of at least a 50% reduction
of pain.[4,16,22,27] LINAC SRS has emerged as a precise,
effective, and noninvasive procedure for the treatment of
TN.[29,32] LINAC SRS is dedicated for targeting within the
central nervous system and offers stereotactically‑guided
irradiation to the trigeminal nerve.[29]
The majority of LINAC SRS studies for TN have used
a frame‑based system with either a Novalis, Varian,
or Primus device,[7,12,13,18,24,26,29,30,35] whereas a few have
reported the innovative frameless technique.[1,8] Table 2
highlights myriad studies in the literature that utilized
a linear accelerator SRS for the treatment of TN. Our
study corresponds with previous studies in that the
patients with TN failed to respond to previous medical
therapy. The vast majority of patients attained either
a good or excellent response to the treatment. The
mean time to pain relief was approximately 4–8 weeks
in most of the studies. The present study concurs with
others that LINAC SRS is an effective and noninvasive
treatment for patients with TN, especially in the older
population. The median ages of the patients ranged
52–85 years; the median age in the present study was

73 years. It has been suggested that radiosurgery is an
appealing option for older patients whose condition is
not receptive to invasive surgical procedures.[29] LINAC
SRS has proven successful, especially in patients who
have not had a previous invasive treatment.[18] In their
study of prognostic factors for radiosurgery treatment of
TN, Chen et al. noted that sensitivity to anticonvulsant
medication was the single most important prognostic
indicator of treatment success for patients presenting
with facial pain.[7] In the present study, patients who did
not undergo prior surgery for TN had a higher odds ratio
for marked or moderate pain relief compared to patients
who had prior surgery (14.9, P = 0.0408). In addition,
patients who had right‑sided TN had a higher odds ratio
for marked or moderate improvement compared to those
who had right‑sided TN (12.9, P = 0.0144). We found a
significant difference that patients who underwent a prior
procedure for TN had better outcomes. Coincidentally,
all the patients with prior procedures had left‑sided
(4 of 12 patients) TN and did worse. It is likely that the
difference in outcome based on laterality is confounded
by prior procedures.
Frameless radiosurgery has recently gained in popularity
because it is a true noninvasive procedure without the
need for anesthetics and sterile processing.[8] In addition,
the frameless system avoids patient discomfort associated
with frame application and is able to treat extracranial
lesions.[5] The frameless approach corrects for positioning
errors automatically due to the imaging guidance during
the procedure.[8] The imaging, planning, and treatment
components may be performed in different sessions. In
this respect, frameless SRS is valuable in developing more
complicated SRS planning over a several day period.
Studies utilizing a head phantom have shown that
intrafraction motion in the BrainLab frameless mask is
minimal[33] and that this innovative technique is valuable
in treating intracranial benign and malignant lesions.[34]
Frameless IGRS has rarely been used to treat TN.[8]
Chen et al. performed a study of 44 patients who

Table 2: SRS using linear accelerator for the treatment of trigeminal neuralgia
Study
Goss et al. 2003
Frighetto et al. 2004
Kubicek et al. 2004
Richards et al. 2005
Pusztaszeri et al. 2007
Chen et al. 2010
Chen et al. 2008
Zahra et al. 2009
Smith et al. 2011
Current Study 2017

N
25
22
20 (23 treatments)
28
17
44
82
20
179
20 (21 treatments)

Dose/Device

Follow‑Up
(Months)

% Good or Excellent
response

90 Gy/Novalis
70-90 Gy/Novalis
82.3-100 Gy/Varian
80 Gy/Varian
40-56 Gy/Primus
90 Gy/Novalis*
85-90 Gy/Novalis
90 Gy/Novalis
70-90 Gy/
80-85 Gy/Novalis*

18 (8‑52)
21.2 (8‑52)
56.5
12 (1‑40)
12 (1‑60)
15
18
14.2
28.8 (5‑142)
32

100
95.4
78
75
100
91
85.3
95
79.3
95

*Indicates frameless image‑guided radiosurgery using Novalis linear accelerator with ExacTrac
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were treated with frameless IGRS over an 18‑month
period.[8] The isocenter dose of 90 Gy was delivered
via a 4‑mm collimator. The median age of patients was
65 years, and their BNI scores were IV or V prior to the
procedure. Before the day of the treatment, the patients
underwent high‑resolution MRI with a 1.0 mm slice
thickness. The overall intrafraction positioning error was
0.49 ± 0.44 mm, and the median time to pain relief was
4 weeks. A total of 40 (91%) patients attained a BNI
score of III or better, whereas 19 (43%) patients achieved
a BNI score of I.

2.

The findings of the present study concur with those of
Chen et al. using frameless IGRS to treat patients with
TN.[8] Our patient population was slightly older than
those of Chen et al. (73 vs 65 years), while the BNI scores
in both studies were either IV or V prior to the procedure.
The MRIs in our study were performed with a 0.6 mm
slice thickness which allowed better visualization of the
area and greater precision in treatment compared to the
work of Chen et al. who used a 1.0 mm slice thickness.
The mean intrafraction shift in our study was 0.43 mm
compared to 0.49 mm in theirs. Nineteen (95%) patients
received a BNI score of III or better following frameless
IGRS in the current study, and 8 (40%) patients attained
complete pain relief with a BNI score of I.

7.

CONCLUSION

3.

4.
5.

6.

8.

9.

10.

11.
12.

13.

The present study describes our initial experience with
treatment of TN using a frameless IGRS procedure in
a multidisciplinary setting. Our data suggest that it is
an effective and noninvasive method of treating TN,
especially in older individuals who are refractory to
medical management. The slice thickness of 0.6 mm
provided increased resolution at the target compared to
previous studies in the literature. This small thickness
coupled with the mapping of the patient’s movement
during treatment allowed us to have a greater confidence
to perform frameless IGRS. Further investigation is
warranted with a larger sample size to confirm the
efficacy of frameless IGRS for TN.
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